Cargando…
Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression.
The c-myc oncogene has been extensively implicated in cell proliferation, cell differentiation and programmed cell death. Aberrant expression of the c-myc gene product has been observed in a range of tumours and has also been implicated in cisplatin (cis-dichlorodiammineplatinum)-mediated chemoresis...
Autores principales: | Walker, T. L., White, J. D., Esdale, W. J., Burton, M. A., DeCruz, E. E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074343/ https://www.ncbi.nlm.nih.gov/pubmed/8605094 |
Ejemplares similares
-
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
por: Turner, N C, et al.
Publicado: (2010) -
Nuclear morphology predicts cell survival to cisplatin chemotherapy
por: Kim, Chi-Ju, et al.
Publicado: (2023) -
Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapy.
por: Fosså, S. D., et al.
Publicado: (1996) -
MYC‐y mice: From tumour initiation to therapeutic targeting of endogenous MYC
por: Morton, Jennifer P., et al.
Publicado: (2013) -
Chemotherapy promotes tumour cell hybridization in vivo
por: Yan, Bingyu, et al.
Publicado: (2015)